Jaguar Health, Inc. (JAGX) Misses Q3 EPS by 4c

Jaguar Health, Inc. (NASDAQ: JAGX) reported Q3 EPS of ($0.12), $0.04 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $3.15 million versus the consensus estimate of $3.55 million.

For earnings history and earnings-related data on Jaguar Health, Inc. (JAGX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Ennis (EBF) Reports In-Line Q1 EPS
• Jaguar Health explores strategic alternatives amid rare disease NDA push